Cargando…
Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
Autores principales: | Feng, Liang, Yao, Hang-Ping, Sharma, Sharad, Zhou, Yong-Qing, Zhou, Jianwei, Zhang, Ruiwen, Wang, Ming-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912733/ https://www.ncbi.nlm.nih.gov/pubmed/27316712 http://dx.doi.org/10.1186/s13046-016-0364-5 |
Ejemplares similares
-
Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
por: Feng, Liang, et al.
Publicado: (2016) -
Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates
por: Fujii, Tomohiro, et al.
Publicado: (2021) -
Targeting the
Phosphatidylserine-Immune Checkpoint
with a Small-Molecule Maytansinoid Conjugate
por: Lo, Chen-Fu, et al.
Publicado: (2022) -
Peptide-Cleavable Self-immolative Maytansinoid Antibody–Drug
Conjugates Designed To Provide Improved Bystander Killing
por: Costoplus, Juliet A., et al.
Publicado: (2019) -
Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids
por: Lo, Chen-Fu, et al.
Publicado: (2022)